Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
Nuvectis Pharma (NVCT) Stock Price & Analysis
33 Followers
NVCT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.21 - $20.92
Previous Close$11.76
Volume7.33K
Average Volume (3M)61.13K
Market Cap
$173.41M
Enterprise Value$153.42M
Total Cash (Recent Filing)$19.99M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-8.0
Beta>-0.01
Next Earnings
May 09, 2023EPS Estimate
-$0.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.48
Shares Outstanding14,642,483
10 Day Avg. Volume94,711
30 Day Avg. Volume61,134
Standard Deviation0.25
R-Squared0.00923
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)7.17
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-14.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-7.98
Forecast
1Y Price Target
$21.00Price Target Upside78.65% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Nuvectis Pharma News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NVCT FAQ
What was Nuvectis Pharma’s price range in the past 12 months?
Nuvectis Pharma lowest stock price was $6.21 and its highest was $20.92 in the past 12 months.
What is Nuvectis Pharma’s market cap?
Currently, no data Available
When is Nuvectis Pharma’s upcoming earnings report date?
Nuvectis Pharma’s upcoming earnings report date is May 09, 2023 which is in 44 days.
How were Nuvectis Pharma’s earnings last quarter?
Nuvectis Pharma released its earnings results on Mar 07, 2023. The company reported -$0.49 earnings per share for the quarter, missing the consensus estimate of -$0.397 by -$0.093.
Is Nuvectis Pharma overvalued?
According to Wall Street analysts Nuvectis Pharma’s price is currently Undervalued.
Does Nuvectis Pharma pay dividends?
Nuvectis Pharma does not currently pay dividends.
What is Nuvectis Pharma’s EPS estimate?
Nuvectis Pharma’s EPS estimate is -$0.44.
How many shares outstanding does Nuvectis Pharma have?
Nuvectis Pharma has 14,752,403 shares outstanding.
What happened to Nuvectis Pharma’s price movement after its last earnings report?
Nuvectis Pharma reported an EPS of -$0.49 in its last earnings report, missing expectations of -$0.397. Following the earnings report the stock price went down -4.706%.
Which hedge fund is a major shareholder of Nuvectis Pharma?
Currently, no hedge funds are holding shares in NVCT
---
Nuvectis Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.00 (78.65% Upside)
$21.00 (78.65% Upside)
Insider Transactions
Bought Shares
Worth $41.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
56.73%
12-Months-Change
Fundamentals
Return on Equity
-206.81%
Trailing 12-Months
Asset Growth
206.52%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nuvectis Pharma
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its pipeline products include NXP800, NXP900.
---
Top 5 ETFs holding NVCT
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold NVCT. The ETFs are listed according to market value of NVCT within the ETF
---
Senti Biosciences
―
Candel Therapeutics
―
GlycoMimetics
―
Alzamend Neuro
―
Olema Pharmaceuticals
―
---